Multidisciplinarity in Myeloid Neoplasms: Bridging Diagnostics and Clinical Insights
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 75
Special Issue Editors
Interests: non-vitamin k antagonist oral anticoagulant (NOAC); prothrombin complex concentrate (PCC); anticoagulation reversal; intracranial hemorrhage; coagulation management
Special Issue Information
Dear Colleagues,
Modern diagnostics in myeloid neoplasms, encompassing conditions such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and MDS/MPN, increasingly rely on interdisciplinary collaboration to achieve accurate and clinically meaningful results. This Special Issue emphasizes the importance of integrating expertise from diverse specialties, including hematopathology and clinical disciplines such as hematology and oncology.
Key Themes:
- Advances in morphological and genetic diagnostics for myeloid neoplasms;
- Collaborative approaches to integrating diagnostic data for clinical decision making;
- The role of multidisciplinary teams in optimizing patient management;
- Innovations in molecular and cytogenetic techniques and their clinical implications.
Through this Special Issue, we aim to underscore the transformative impact of multidisciplinary collaboration in hematologic diagnostics.
Dr. Alexander Haushofer
Guest Editor
Dr. Bernhard Strasser
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute myeloid leukemia (AML)
- myelodysplastic syndromes (MDS)
- myeloproliferative neoplasms (MPN)
- MDS/MPN genetic profiling
- multidisciplinary collaboration
- diagnostic innovation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
